Tuberculosis News and Research

Latest Tuberculosis News and Research

FIRS calls on governments and policymakers to support and promote tobacco cessation services

On World No Tobacco Day (31 May, 2021) the Forum of International Respiratory Societies (FIRS), of which the American College of Chest Physicians® (CHEST) is a founding member, calls on governments and policymakers to make greater political and financial commitments to support and promote tobacco cessation services.

29 May 2021

Can certain aircraft boarding procedures increase SARS-CoV-2 transmission risks?

In a study published in the Royal Society Open Science journal, researchers simulated many aircraft boarding processes to assess their impact on social proximity during boarding. They also studied the dominant mechanisms by which these processes generate social proximity. The researchers systematically measured proximity by measuring the number of contacts originating from the following situations: 1. contacts between seated passenger pairs; 2. contacts between aisle passenger pairs; and 3. contacts between a seated passenger and an aisle passenger.

26 May 2021

Zoonotic and vector-borne emerging tropical diseases pose a constant threat

A recent article published in the journal Frontiers in Tropical Diseases assessed the threat of emerging zoonotic and vector-borne tropical diseases.

26 May 2021

Scientists propose new strategies to find drugs that neutralize critical enzymes

Scientists from the University of Bath explore racemases and propose strategies for finding drugs that target these important enzymes.

26 May 2021

Study: Four-month regimen of anti-TB drugs works just as well as standard regimen

A new four-month regimen of anti-TB drugs that includes rifapentine and moxifloxacin works just as well as the standard six-month regimen, according to a study.

24 May 2021

Despite pandemic, Newsom declines to boost local public health budgets — again

In spite of a pandemic that has killed about 62,000 Californians — more than enough to pack Dodger Stadium — Gov. Gavin Newsom has again declined to boost the budgets of the state's underfunded and understaffed local public health departments.

20 May 2021

Four months of multi-drug therapy for tuberculosis is as effective as standard regimen

Four months of multi-drug therapy that included rifapentine and moxifloxacin treated active tuberculosis (TB) as effectively as the standard six-month regimen in a multinational study, cutting treatment time by a third.

20 May 2021

Study provides new basis to compare the effectiveness of different tuberculosis treatments

A new study published in Nature Communications provides an important new basis for comparing the effectiveness of different tuberculosis treatments.

18 May 2021

Measuring metabolic 'fluxes' could help scientists advance new tuberculosis drugs

Mycobacterium tuberculosis is incredible in that it can survive for decades within its human host. It does this by varying its diet to successfully steal nutrients from the human host including immune cells; it is known to acquire and absorb multiple carbon sources from the body during infection.

12 May 2021

Study discovers harmful inflammatory protein in patients with symptomatic tuberculosis

A pioneering study by UCL scientists has discovered the presence of a harmful inflammatory protein in patients with symptomatic tuberculosis (TB).

10 May 2021

High rates of TB in Latin American prisons constitute a “health and human rights crisis”, warns study

High rates of tuberculosis (TB) in Latin American prisons are subverting efforts to control the disease in the wider population, and constitute a "health and human rights crisis", a study warns.

5 May 2021

New findings on the support and barriers to combat TB in high-burden countries

Nine out of ten cases of tuberculosis appear in 30 identified low and middle-income countries, each of which has a national tuberculosis programme.

3 May 2021

Designing effective multidrug-resistant-TB treatments based on DNA sequencing

Globally, tuberculosis is the most common bacterial infectious disease leading to death. The pathogen causing tuberculosis, Mycobacterium tuberculosis, has a number of peculiarities. One is that it is growing very slowly.

3 May 2021

Fighting malaria in 2021: Where are we now and where are we going?

In support of World Malaria Day, News-Medical spoke to Dr. Laurence Slutsker, an internationally recognized expert in malaria, about fighting this disease in 2021.

26 Apr 2021

Disruptions to essential health services due to COVID-19 pandemic persist in 90% of countries

The second round of a World Health Organization "pulse survey" reveals that over one year into the COVID-19 pandemic, substantial disruptions persist, with about 90% of countries still reporting one or more disruptions to essential health services, marking no substantial global change since the first survey conducted in the summer of 2020.

23 Apr 2021

Widely available HIV testing and treatment services increase life expectancy

Life expectancy among adults living with HIV receiving antiretroviral therapy (ART) in Latin America and the Caribbean has increased significantly since HIV testing and treatment services became more widely available, according to research published today in The Lancet HIV journal.

21 Apr 2021

Overwhelming evidence SARS-CoV-2 is airborne

Researchers in the United States, UK, and Canada have published a commentary challenging the suggestion that the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may not be airborne.

18 Apr 2021

Study reveals new lineage of tuberculosis-causing bacteria in the eastern part of the continent

Mireia Coscollá, a researcher at the Institute for Integrative Systems Biology (I2SysBio), a joint centre of the University of Valencia and the Spanish National Research Council, has led a study on the bacterium that causes tuberculosis, one of the 10 deadliest diseases in the world, which proves the existence of a new lineage.

16 Apr 2021

Researchers unravel the molecular basis of how Mtb uses and transports an essential sugar

Tuberculosis is a devastating disease that claims over 1.5 million lives each year. The increase in TB cases that are resistant to the current antibiotics means that novel drugs to kill Mycobacterium tuberculosis (Mtb) are urgently needed.

15 Apr 2021

New discovery offers hope for improving treatments for tuberculosis

The immune response to tuberculosis (TB) differs in adults and newborn babies due to the way immune cells use energy to kick into gear in a bid to kill the bacteria.

13 Apr 2021

Tuberculosis News and Research

Latest Tuberculosis News and Research

FIRS calls on governments and policymakers to support and promote tobacco cessation services

Can certain aircraft boarding procedures increase SARS-CoV-2 transmission risks?

Zoonotic and vector-borne emerging tropical diseases pose a constant threat

Scientists propose new strategies to find drugs that neutralize critical enzymes

Study: Four-month regimen of anti-TB drugs works just as well as standard regimen

Despite pandemic, Newsom declines to boost local public health budgets — again

Four months of multi-drug therapy for tuberculosis is as effective as standard regimen

Study provides new basis to compare the effectiveness of different tuberculosis treatments

Measuring metabolic 'fluxes' could help scientists advance new tuberculosis drugs

Study discovers harmful inflammatory protein in patients with symptomatic tuberculosis

High rates of TB in Latin American prisons constitute a “health and human rights crisis”, warns study

New findings on the support and barriers to combat TB in high-burden countries

Designing effective multidrug-resistant-TB treatments based on DNA sequencing

Fighting malaria in 2021: Where are we now and where are we going?

Disruptions to essential health services due to COVID-19 pandemic persist in 90% of countries

Widely available HIV testing and treatment services increase life expectancy

Overwhelming evidence SARS-CoV-2 is airborne

Study reveals new lineage of tuberculosis-causing bacteria in the eastern part of the continent

Researchers unravel the molecular basis of how Mtb uses and transports an essential sugar

New discovery offers hope for improving treatments for tuberculosis

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Tuberculosis News and Research

Latest Tuberculosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in